Annovis Bio, Inc. Earnings Per Share (Basic)
Annovis Bio, Inc. (ANVS) reported Earnings Per Share (Basic) of -$0.40 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Annovis Bio, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.40.
- Annovis Bio, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.63.
- Annovis Bio, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.38.
- Annovis Bio, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.37.
- Annovis Bio, Inc. earnings per share, basic for fiscal 2025 was -$1.40.
- Annovis Bio, Inc. earnings per share, basic for fiscal 2024 was -$2.02.
- Annovis Bio, Inc. earnings per share, basic for fiscal 2023 was -$6.23.
- Annovis Bio, Inc. earnings per share, basic for fiscal 2022 was -$3.10.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.40 10-Q · filed 2026-08-14 | -$0.99 10-Q · filed 2026-08-14 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.79 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2026-03-31 | -$0.63 10-Q · filed 2026-05-15 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.42 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.40 10-K · filed 2026-03-13 | |||
| 2025-09-30 | -$0.37 10-Q · filed 2025-11-12 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.01 10-Q · filed 2025-11-12 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-06-30 | -$0.32 10-Q · filed 2026-08-14 | -$0.64 10-Q · filed 2026-08-14 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-03-31 | -$0.32 10-Q · filed 2026-05-15 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.60 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.07 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2024-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1.82 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$2.02 10-K · filed 2026-03-13 | |||
| 2024-09-30 | -$0.97 10-Q · filed 2025-11-12 | -$1.45 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.64 10-Q · filed 2025-11-12 | -$3.65 derived: net income ÷ weighted average shares · filed 2025-11-12 | |||
| 2024-06-30 | -$0.44 10-Q · filed 2025-08-12 | -$0.56 10-Q · filed 2025-08-12 | -$2.67 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$4.21 derived: net income ÷ weighted average shares · filed 2025-11-12 | |||
| 2024-03-31 | -$0.10 10-Q · filed 2025-05-13 | -$2.27 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$3.86 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$4.94 derived: net income ÷ weighted average shares · filed 2025-11-12 | |||
| 2023-12-31 | -$2.24 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$3.90 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$5.00 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$6.23 10-K · filed 2025-03-21 | |||
| 2023-09-30 | -$1.63 10-Q · filed 2024-11-08 | -$2.70 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$3.90 10-Q · filed 2024-11-08 | -$4.86 derived: net income ÷ weighted average shares · filed 2024-11-08 | |||
| 2023-06-30 | -$1.07 10-Q · filed 2024-08-14 | -$2.25 10-Q · filed 2024-08-14 | -$3.20 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$4.00 derived: net income ÷ weighted average shares · filed 2024-11-08 | |||
| 2023-03-31 | -$1.19 10-Q · filed 2024-05-10 | -$2.14 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$2.92 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$3.65 derived: net income ÷ weighted average shares · filed 2024-11-08 | |||
| 2022-12-31 | -$0.95 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$1.73 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$2.46 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$3.10 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$0.79 10-Q · filed 2023-11-08 | -$0.93 10-Q · filed 2022-11-08 | -$1.51 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.16 10-Q · filed 2023-11-08 | -$2.72 10-Q · filed 2022-11-08 | -$2.89 derived: net income ÷ weighted average shares · filed 2023-11-08 | |
| 2022-06-30 | -$0.73 10-Q · filed 2023-08-14 | -$1.07 10-Q · filed 2022-08-08 | -$1.37 10-Q · filed 2023-08-14 | -$1.79 10-Q · filed 2022-08-08 | -$2.10 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.45 derived: net income ÷ weighted average shares · filed 2023-11-08 | |
| 2022-03-31 | -$0.64 10-Q · filed 2023-05-10 | -$0.72 10-Q · filed 2022-05-04 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.72 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.08 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||
| 2021-12-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.08 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.44 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.90 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$0.35 10-Q · filed 2022-11-08 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.15 10-Q · filed 2022-11-08 | -$1.40 derived: net income ÷ weighted average shares · filed 2022-11-08 | |||
| 2021-06-30 | -$0.34 10-Q · filed 2022-08-08 | -$0.80 10-Q · filed 2022-08-08 | -$1.05 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.20 derived: net income ÷ weighted average shares · filed 2022-11-08 | |||
| 2021-03-31 | -$0.46 10-Q · filed 2022-05-04 | -$0.71 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||
| 2020-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2022-03-02 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-03-02 | -$0.87 10-K · filed 2022-03-02 | ||||
| 2020-09-30 | -$0.15 10-Q · filed 2021-11-03 | -$0.61 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |